Combining high risk science with ambitious social and economic goals

Pharmaceutical Biology

Volumn 37, Issue SUPPL., 1999, Pages 6-21

  Rosenthal, J P ^a   Beck, D ^a   Bhat, A ^a   Biswas, J ^a   Brady, L ^a   Bridbord, K ^a   Collins, S ^a   Cragg, G ^a   Edwards, J ^a   Fairfield, A ^a   Gottlieb, M ^a   Gschwind, L A ^a   Hallock, Y ^a   Hawks, R ^a   Hegyeli, R ^a   Johnson, G ^a   Keusch, G T ^a   Lyons, E E ^a   Miller, R ^a   Rodman, J ^a   Roskoski, J ^a   Siegel Causey, D ^a   more..

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biodiversity conservation; Drug discovery; Economic development; Natural products; Patents; Research; Traditional knowledge; Training

Indexed keywords

DRUG;

ARTHROPOD; ARTICLE; BIODIVERSITY; ECONOMICS; PLANT; RESEARCH; SCIENCE;

ARTHROPODA;

EID: 0033291691     PISSN: 13880209     EISSN: None     Source Type: Journal    
DOI: 10.1076/1388-0209(200010)37:sup;1-w;ft006     Document Type: Article

References (52)

1. Report of a special panel of experts on the International Cooperative Biodiversity Groups (ICBG)
2. Applying ecological research at integrated conservation and development projects
3. Natural product drug discovery and development: New perspectives on international collaboration
4. $3M deal launches major hunt for drug leads in Brazil
5. Discovery and development of antineoplastic agents from natural sources
6. Patenting recipes from nature's kitchen: How can a naturally occurring chemical like taxol be patented?
7. New rules for natural products research
8. Agreements to collect biodiversity for pharmaceutical research: Major issues and proposed principles
9. The origins of prescription drugs
10. Chemical prospecting: An overview of the International Cooperative Biodiversity Groups Program
11. Implementing the biodiversity treaty: How to make international cooperative agreements work
12. Gardenification of tropical conserved wildlands: Multitasking, multicropping, and multiusers
13. Patterns of use of large moth caterpillars (Lepidoptera: Saturniidae and Sphingidae) by ichneumonid parasitoids (Hymenoptera) in Costa Rican dry forest
14. The Suriname International Cooperative Biodiversity Group Program: Lessons from the first five years
15. Biodiversity conservation, economic development, and drug discovery in Suriname
16. How many leads from HTS?
17. Lepidoptera of the Cordillera del Condor
18. Peruvian medicinal plant sources of new pharmaceuticals (International Cooperative Biodiversity Group-Peru)
19. When rhetoric hits reality in debate on bioprospecting
20. The complex realities of sharing genetic assets
21. Chemical biology of epothilones
22. Request for Applications (RFA TW-92-01) International Cooperative Biodiversity Groups
23. Request for Applications (RFA TW-98-001) International Cooperative Biodiversity Groups
24. Biological products raise genetic ownership issues: Governments are demanding share of profits
25. Equitable sharing of biodiversity benefits: Agreements on genetic resources
26. Integrating drug discovery, biodiversity conservation, and economic development: Early lessons from the International Cooperative Biodiversity Groups
27. Drug development and conservation of biodiversity in West and Central Africa: A new standard of collaboration with indigenous people
28. Summary of the workshop on drug development, biological diversity and economic growth
29. Plant patent killed
30. Combinatorial chemistry hits the drug market
31. Drug industry looks to the lab instead of rainforest and reef
32. Valuing biodiversity for use in pharmaceutical research
33. Costa Rican International Cooperative Biodiversity Group: Using insects and other arthropods in biodiversity prospecting
34. Taller Internacional: Aspectos Ambientales, Eticos. Ideologicos y Politicos en el Debate sobre Bioprospeccion y Uso de Recursos Geneticos en Chile
35. Biodiversity prospecting models for collection resources: The NIH/NSF/USAID model
36. Lignans from Chilean propolis
37. Human tissue research: Who owns the results?